Zobrazeno 1 - 2
of 2
pro vyhledávání: '"W. N. William Junior"'
Autor:
E. S. Kim, R. S. Weber, Charles Lu, W. N. William Junior, Anita L. Sabichi, Lawrence E. Ginsberg, Amy C. Hessel, R. Ayuste, Scott M. Lippman, J. Jack Lee, Erich M. Sturgis, Ehab Y. Hanna, Merrill S. Kies, J.N. Myers, Stephen Y. Lai, Adel K. El-Naggar
Publikováno v:
Journal of Clinical Oncology. 29:5520-5520
5520 Background: In EGFR over expressing cell lines, higher doses of erlotinib block downstream signaling more effectively (e.g., MAPK) than lower doses, despite a similar degree of EGFR phosphoryl...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9e3b27b75e1c9014cc2c3f2a9cf0831
https://doi.org/10.1200/jco.2011.29.15_suppl.5520
https://doi.org/10.1200/jco.2011.29.15_suppl.5520
Autor:
R. W. Jacobs, W. N. William Junior, A. M. Litvak, X. Gu, Curtis R. Pickering, Jangsoon Lee, Maria I. Nunez, J.N. Myers, Adel K. El-Naggar, Bonnie S. Glisson
Publikováno v:
Journal of Clinical Oncology. 28:5548-5548
5548 Background: We studied associations between recurrence-free survival (RFS) and expression levels of hypoxia-inducible factor-1 alpha (HIF-1a) and its activated (phosphorylated) upstream molecules mammalian target of rapamycin (mTOR), epidermal g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e64f1473153898acc02fa2a6c9b4f79
https://doi.org/10.1200/jco.2010.28.15_suppl.5548
https://doi.org/10.1200/jco.2010.28.15_suppl.5548